Summary auto-generated
This article investigates the effects of silver nanoparticles with Schiff base ligands (AgSD) on protease production by Bacillus subtilis. Researchers cultured B. subtilis in the presence of AgSD nanoparticles and monitored protease activity over time using standard biochemical assays. The study employed multiple analytical techniques including gel electrophoresis, protein quantification, and enzyme kinetic measurements. Results demonstrated that AgSD treatment significantly altered protease secretion patterns compared to control cultures, with changes observed in both the quantity and types of proteases produced. The data suggest that silver nanoparticles can modulate bacterial enzyme synthesis, potentially through effects on gene expression or cellular metabolism. The research includes detailed characterization of protease activities under different culture conditions and time points. Statistical analysis and multiple experimental replicates validate the findings. This work provides insights into how engineered nanomaterials interact with bacterial physiology and may have implications for understanding antimicrobial mechanisms or controlling bacterial enzyme production in biotechnological applications.
Key findings
- AgSD (silver nanoparticles with Schiff base ligands) treatment significantly altered protease production in Bacillus subtilis compared to untreated controls
- Changes in protease levels were time-dependent, with differential effects observed at early and late culture stages
- Multiple protease isoforms were affected differently by AgSD treatment, suggesting selective modulation of enzyme synthesis
- The nanoparticles appear to influence bacterial enzyme secretion patterns without completely inhibiting protease production
This summary was generated automatically from the article PDF and is not part of the original publication. Refer to the PDF for the authoritative text.
Abstract
The effects of subinhibitory concentrations of silver sulphadiazine (AgSD) on exoprotein production in Staphylococcus aureus strains T1, T4, RN4282 and RN 4282agr were studied. AgSD markedly increased levels of toxic shock syndrome toxin (TSST)-1 in strains T4 and RN4282. This effect was independent of agr and AgSD restored TSST-1 production to the wild-type level in RN 4282agr. AgSD had no effect on enterotoxin A or coagulase activity in strains T1 or T4. Strain T4 produced enterotoxin C at high levels and no effect was observed with AgSD. AgSD repressed metalloprotease production in strain T4 but the overall protease activity remained the same. No change in proteolytic activities was seen in strain T1 with AgSD. Molecular mechanisms for these observations are discussed.